Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors

Provided By PR Newswire

Last update: Mar 21, 2024

BETHESDA, Md., March 21, 2024 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax^® personalized immune therapies for solid tumor cancers, announced today that it has appointed Mr. Pat Sarma to its Board of Directors effective March 18, 2024.